Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

An African Ancestry–Enriched H1 Sub-Haplotype Challenges MAPT Haplotype Assignment and Reveals Distinct Tau Regulatory Programs

ABSTRACT: The 17q21.31 inversion locus is among the strongest genetic modifiers of tau-related neurodegenerative disease, yet its structure and function across ancestries remain incompletely understood. By integrating long-read sequencing, transcriptomics from postmortem human brain tissue, and iPSC-derived neurons and astrocytes, we identified H1_A, a previously unrecognized non-inverted H1 sub-haplotype enriched in individuals of African ancestry. H1_A carries rs8070723, a variant widely used to define the protective H2 haplotype, revealing limitations of current MAPT haplotype assignment in non-European populations. Across brain tissue and neural cell types, ancestry and haplotype influenced MAPT expression, tau isoform composition, extracellular matrix pathways, immune signaling, and oxidative stress responses. Functional studies further demonstrated effects on astrocyte migration and glutathione regulation. These findings uncover ancestry-dependent regulatory programs at 17q21.31 and provide a framework for more accurate interpretation of MAPT-associated risk in neurodegenerative disease.

ORGANISM(S): Homo sapiens

PROVIDER: GSE335291 | GEO | 2026/09/18

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

An African Ancestry–Enriched H1 Sub-Haplotype Challenges MAPT Haplotype Assignment and Reveals Distinct Tau Regulatory Programs

Project description:The 17q21.31 inversion locus is among the strongest genetic modifiers of tau-related neurodegenerative disease, yet its structure and function across ancestries remain incompletely understood. By integrating long-read sequencing, transcriptomics from postmortem human brain tissue, and iPSC-derived neurons and astrocytes, we identified H1_A, a previously unrecognized non-inverted H1 sub-haplotype enriched in individuals of African ancestry. H1_A carries rs8070723, a variant widely used to define the protective H2 haplotype, revealing limitations of current MAPT haplotype assignment in non-European populations. Across brain tissue and neural cell types, ancestry and haplotype influenced MAPT expression, tau isoform composition, extracellular matrix pathways, immune signaling, and oxidative stress responses. Functional studies further demonstrated effects on astrocyte migration and glutathione regulation. These findings uncover ancestry-dependent regulatory programs at 17q21.31 and provide a framework for more accurate interpretation of MAPT-associated risk in neurodegenerative disease.

2026-09-18 | GSE335293 | GEO

An African Ancestry–Enriched H1 Sub-Haplotype Challenges MAPT Haplotype Assignment and Reveals Distinct Tau Regulatory Programs

2026-09-18 | GSE335405 | GEO

Ancestry-Specific Structural Variation at 17q21.31 Reveals a Novel H1 Sub-Haplotype and Functional Effects on Tau Biology

Project description:This study investigates how structural variation at the 17q21.31 locus influences MAPT transcript diversity across ancestries and cellular contexts. The locus contains the H1 and H2 haplotypes, which differ by a large inversion and are associated with distinct risks for neurodegenerative disease. To characterize ancestry- and haplotype-specific tau isoform expression, targeted long-read Iso-Seq was performed on human postmortem brain tissue samples from caudate and Middle Frontal Gyrus, as well as induced pluripotent stem cell–derived neurons and astrocytes. Samples represented multiple haplotype groups and ancestries, including a newly identified African-enriched H1 sub-haplotype (H1_A). Full-length transcript sequencing was used to identify known and novel MAPT isoforms, quantify relative isoform usage, and compare splicing patterns across tissues and cell types. These data provide a resource for understanding how population-specific genomic structure at 17q21.31 may shape tau biology and neurodegenerative disease susceptibility.

2026-05-31 | GSE328854 | GEO

Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response

Project description:Tau (MAPT) is a microtubule-associated protein causing frequent neurodegenerative diseases or inherited frontotemporal lobar degenerations. Emerging evidence for non-canonical functions of Tau in DNA protection and P53 regulation suggests its involvement in cancer. Indeed, Tau expression correlates with cancer-specific survival or response to microtubule therapeutics. These data may imply common molecular pathways involved in the pathogenesis of neurodegenerative disorders and cancer. To bring new evidence that Tau represents a key protein in cancer, we present an in silico pan-cancer analysis of MAPT transcriptomic profile in over 11000 clinical samples and over 1300 pre-clinical samples provided by the TCGA and the DEPMAP datasets respectively. We completed this analysis by exploring a possible interplay of MAPT with wild-type or mutated P53. Then, we calculated the impact of MAPT expression on clinical outcome and drug response. Overall, the results support a relevant role of the MAPT gene in several cancer types, although the contribution of Tau to cancer appears to very much depend on the cellular context.

2022-11-27 | E-MTAB-8166 | biostudies-arrayexpress

MAPT expression is mediated by long-range interactions with cis-regulatory elements [scMultiomics]

Project description:Tau is encoded by MAPT and abnormal aggregates of tau are a hallmark of a group of neurodegenerative diseases called tauopathies. MAPT is lowly expressed in neural progenitor cells (NPCs), but it is more highly expressed in oligodendrocytes, astrocytes, and neurons that derive from NPCs. This expression switch at differentiation suggests that MAPT expression is controlled by transcription factors and cis-regulatory elements specific to these differentiated cell types, including neurons.

2023-04-12 | GSE228120 | GEO

MAPT expression is mediated by long-range interactions with cis-regulatory elements [RNA_timecourse]

2023-04-12 | GSE228119 | GEO

MAPT expression is mediated by long-range interactions with cis-regulatory elements [RNA-seq]

2023-04-12 | GSE228115 | GEO